Tolebrutinib, a Brain-penetrant Bruton s Tyrosine Kinase Inhibitor, for the Modulation of Chronically Inflamed White Matter Lesions in Multiple Sclerosis

Condition:   Multiple Sclerosis
Interventions:   Drug: tolebrutinib 60mg;   Drug: tolebrutinib 120mg
Sponsor:   National Institute of Neurological Disorders and Stroke (NINDS)
Recruiting


Author: